☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
ARVO
Samsung Bioepis Presents Results of SB11 (proposed biosimilar ranibizumab) at ARVO 2021
May 3, 2021
Novartis Presents Results of Beovu (brolucizumab -dbll) in P-III KESTREL and KITE Studies for Diabetic Macular Edema at ARVO2021
May 3, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.